Robert Carter reports stock transactions at DGX
By AlphaYouPublished Form 4
CARTER ROBERT B
Reporting filer
Robert Carter reports stock transactions, not an open-market purchase or sale, in Quest Diagnostics Inc. Form 4 filed Oct 23, 2026 lists 1 entry.
- Disclosed
- Oct 23, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | CARTER ROBERT B | 2026-10-21 | L | Code L (see filing) | 10 | 235.93 | 3,874 | 2 days | Filed terms
|
Common Stock
- Owner
- CARTER ROBERT B
- Date
- 2026-10-21
- Code
- L
- Action
- Code L (see filing)
- Quantity
- 10
- Price
- 235.93
- Following holdings
- 3,874
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-21
- transaction Form Type: 5
- transaction Code: L
- equity Swap Involved: 0
- transaction Timeliness: E
- transaction Shares: 10
- id: F1
- transaction Price Per Share: 235.93
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 3874
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- CARTER ROBERT B: Director.
- F1: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.
Original sources
Prepared automatically from public filing data. Report a correction.